Skip to main content

Capcom Financial Data Reveals Resident Evil Cumulative Sales Reach 218 Million Copies!

As of the end of September 2026, the cumulative global sales of the Resident Evil series reached 218 million units, continuing to top Capcom's franchises. Its cumulative sales were approximately 213 million units by the end of June that year, an increase of about 5 million units over three months.

卡普空财务数据称《生化危机》累计销量达2.18亿套!

Related data attributes the growth during this period to the market performance of Resident Evil Requiem and continued sales of older titles. Resident Evil Requiem has accumulated sales of 8.51 million units, while titles such as Resident Evil 2 and Resident Evil 4 Remake continue to contribute to sales.

卡普空财务数据称《生化危机》累计销量达2.18亿套!

Among other Capcom franchises, Monster Hunter ranked second with 132 million units, and Street Fighter ranked third with 60 million units. They were followed by Mega Man with 45 million units, Devil May Cry with 42 million units, Dead Rising with 19 million units, Ace Attorney with 15 million units, Dragon's Dogma with 14 million units, Marvel vs. Capcom with 13 million units, and Onimusha with 11 million units.

卡普空财务数据称《生化危机》累计销量达2.18亿套!

The data also lists that Onimusha: Way of the Sword, released in September 2026, sold 1.78 million units. The sales figures for individual titles still need to be verified against the statistical methodology used in Capcom's original financial reports.